Overview

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-8025 (KRP-197) in patients with overactive bladder.
Phase:
Phase 3
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd